12don MSN
Novel compound attacks tuberculosis bacteria's ATP synthase, showing promise against drug resistance
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...
Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...
By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...
The University of Liverpool's Centre of Excellence for Long-acting Therapeutics - Global Health (CELT Global Health) is part of a new public-private ...
CELT Global Health part of new initiative to accelerate innovation against drug-resistant bacterial infections ...
The main market opportunities lie in expanding Whole Genome Sequencing at birth, rapid growth in Direct to Consumer Testing, advancing sequencing technologies, and overcoming industry barriers.
Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...
Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, insurance portfolio management, finance and accounting, personal investment and financial ...
This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...
Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results